
View larger version (24K):
[in this window]
[in a new window]
|
Fig. 2. LFY and UFO physically interact. (A) UFO induces a supershift
of a LFY-DNA complex. Electrophoretic mobility shift assay (EMSA) using an
AP3 promoter sequence. BMV, non-specific brome mosaic virus control;
LFY, in vitro transcribed and translated LFY protein; UFO, in vitro
transcribed and translated UFO protein; LFY+UFO lane shows a supershift of the
LFY-DNA complex, while UFO alone does not bind to the AP3 promoter
sequence, indicating that UFO binds to the LFY-DNA complex. (B) Upper
panel: GST pull-down assay showing interaction between a bacterially produced
GST-LFY fusion protein and 35S-labeled UFO protein; GST alone does
not show an interaction with UFO. Input lane represents 10% of total protein.
Lower panel shows same blot probed with GST antibody, demonstrating
equivalent loading of GST and GST-LFY lanes. (C) Interaction of LFY and
UFO in yeast two-hybrid assays. The AD-LFY/BD-UFO interaction shows a
significant increase in β-gal activity over background controls. This
interaction is enhanced 8.6-fold when the F-box is deleted in the
AD-LFY/BD- FUFO combination compared with that of AD-LFY/BD-UFO.
AD- FUFO and BD-LFY also shows a significant interaction, while AD-UFO
and BD-LFY shows a background level of β-gal activity. AD, Gal4
activation domain; BD, Gal4 DNA-binding domain. Bars represent
mean±s.e.m. for five replicates. (D) Co-immunoprecipitation of
UFO-Myc with LFY-FLAG in planta. Protein from wild-type, 35S::LFY-FLAG,
35S::UFO-Myc; ufo-2 (LF; UM) or 35S::UFO-Myc (UM) floral buds
were used to precipitate the LFY immune complex using -FLAG. For
control immunoprecipitations, normal mouse IgG serum conjugated to agarose
beads was used. Myc-tagged UFO specifically co-precipitated with LFY-FLAG from
35S::LFY-FLAG, 35S::UFO-Myc tissue only.
|